HLA-DRB1 risk alleles for RA are associated with differential clinical responsiveness to abatacept and adalimumab: data from a head-to-head, randomized, single-blind study in autoa...

por Rigby, William, Buckner, Jane H., Louis Bridges, S., Nys, Marleen, Gao, Sheng, Polinsky, Martin, Ray, Neelanjana, Bykerk, Vivian
Publicado 2021

Treatment of De Novo Renal Transplant Recipients With Calcineurin Inhibitor–free, Belatacept Plus Everolimus–based Immunosuppression

por Peddi, V. Ram, Marder, Bradley, Gaite, Luis, Oberholzer, Jose, Goldberg, Ryan, Pearson, Thomas, Yang, Harold, Allamassey, Lisa, Polinsky, Martin, Formica, Richard N.
Publicado 2023

Phase I study of single‐dose pharmacokinetics and pharmacodynamics of belatacept in adolescent kidney transplant recipients

por Moudgil, Asha, Dharnidharka, Vikas R., Feig, Daniel I., Warshaw, Barry L., Perera, Vidya, Murthy, Bindu, Roberts, Mustimbo E., Polinsky, Martin S., Ettenger, Robert B.
Publicado 2019

Safety and Tolerability Study of an Intravenously Administered Small Interfering Ribonucleic Acid (siRNA) Post On-Pump Cardiothoracic Surgery in Patients at Risk of Acute Kidney In...

por Demirjian, Segav, Ailawadi, Gorav, Polinsky, Martin, Bitran, Dani, Silberman, Shuli, Shernan, Stanton Keith, Burnier, Michel, Hamilton, Marta, Squiers, Elizabeth, Erlich, Shai, Rothenstein, Daniel, Khan, Samina, Chawla, Lakhmir S.
Publicado 2017